Literature DB >> 16132342

Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Cletus Nunes1, Arumugam Mahendrasingam, Raj Suryanarayanan.   

Abstract

PURPOSE: The aim of this study was to develop a highly sensitive powder X-ray diffraction (XRD) technique for quantification of crystallinity in substantially amorphous pharmaceuticals, utilizing synchrotron radiation and a 2-D area detector.
METHODS: Diffraction data were acquired at the European Synchrotron Radiation Facility (France) using a 2-D charge-coupled device detector. The crystallization of amorphous sucrose was monitored in situ, isothermally at several temperatures in the range of 90 to 160 degrees C. An algorithm was developed for separation of the crystalline and amorphous intensities from the total diffraction pattern.
RESULTS: The synchrotron XRD technique allowed powder diffraction patterns to be recorded with a time resolution of 40 ms. The gradual crystallization of sucrose is analogous to a series of physical mixtures with increasing content of the crystalline component. The in situ crystallization approach circumvented the problem of inhomogeneity in mixing--a potentially serious issue at extreme mixture compositions. The estimated limit of detection of crystalline sucrose in an amorphous matrix was 0.2% w/w, a considerable improvement over the reported value of approximately 1% w/w with a conventional XRD.
CONCLUSION: High-intensity XRD can discern subtle changes in the lattice order of materials. The first evidence of crystallization can serve as an indicator of the potential physical instability of the product.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132342     DOI: 10.1007/s11095-005-7626-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice.

Authors: 
Journal:  Fed Regist       Date:  2000-12-29

2.  Some pharmaceutical properties of novobiocin.

Authors:  J D MULLINS; T J MACEK
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1960-04

3.  The quantitative analysis of crystallinity using FT-Raman spectroscopy.

Authors:  L S Taylor; G Zografi
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

4.  Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods.

Authors:  D B Black; E G Lovering
Journal:  J Pharm Pharmacol       Date:  1977-11       Impact factor: 3.765

Review 5.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

Review 6.  Pharmaceutical solids: a strategic approach to regulatory considerations.

Authors:  S Byrn; R Pfeiffer; M Ganey; C Hoiberg; G Poochikian
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

7.  Decreased protein-stabilizing effects of cryoprotectants due to crystallization.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

8.  Stability and several physical properties of amorphous and crystalline form of indomethacin.

Authors:  H Imaizumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-09       Impact factor: 1.645

9.  Non-isothermal and isothermal crystallization of sucrose from the amorphous state.

Authors:  A Saleki-Gerhardt; G Zografi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

10.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-01       Impact factor: 1.645

View more
  18 in total

1.  Investigation of the multi-step dehydration reaction of theophylline monohydrate using 2-dimensional powder X-ray diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-09-01       Impact factor: 4.200

2.  Selective imaging of active pharmaceutical ingredients in powdered blends with common excipients utilizing two-photon excited ultraviolet-fluorescence and ultraviolet-second order nonlinear optical imaging of chiral crystals.

Authors:  S J Toth; J T Madden; L S Taylor; P Marsac; G J Simpson
Journal:  Anal Chem       Date:  2012-06-27       Impact factor: 6.986

3.  Parts per Million Powder X-ray Diffraction.

Authors:  Justin A Newman; Paul D Schmitt; Scott J Toth; Fengyuan Deng; Shijie Zhang; Garth J Simpson
Journal:  Anal Chem       Date:  2015-10-22       Impact factor: 6.986

4.  Glycine crystallization in frozen and freeze-dried systems: effect of pH and buffer concentration.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Prakash Sundaramurthi; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

5.  Solute crystallization in frozen systems-use of synchrotron radiation to improve sensitivity.

Authors:  Dushyant B Varshney; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

Review 6.  Structural Analysis of Molecular Materials Using the Pair Distribution Function.

Authors:  Maxwell W Terban; Simon J L Billinge
Journal:  Chem Rev       Date:  2021-11-17       Impact factor: 60.622

7.  Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders.

Authors:  Umesh S Kestur; Duangporn Wanapun; Scott J Toth; Lindsay A Wegiel; Garth J Simpson; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2012-07-30       Impact factor: 3.534

8.  Phase transitions in frozen systems and during freeze-drying: quantification using synchrotron X-ray diffractometry.

Authors:  Dushyant B Varshney; Prakash Sundaramurthi; Satyendra Kumar; Evgenyi Y Shalaev; Shin-Woong Kang; Larry A Gatlin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-03-27       Impact factor: 4.200

9.  Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).

Authors:  Chris Brough; Dave A Miller; Justin M Keen; Shawn A Kucera; Dieter Lubda; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-12-04       Impact factor: 3.246

10.  Multifunctional chitosan-magnetic graphene quantum dot nanocomposites for the release of therapeutics from detachable and non-detachable biodegradable microneedle arrays.

Authors:  Richard Justin; Biqiong Chen
Journal:  Interface Focus       Date:  2018-04-20       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.